Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Preferred Dividend Payments (2016 - 2020)

Perspective Therapeutics' Preferred Dividend Payments history spans 11 years, with the latest figure at $3000.0 for Q3 2020.

  • For Q3 2020, Preferred Dividend Payments changed 0.0% year-over-year to $3000.0; the TTM value through Jun 2021 reached $3000.0, down 72.73%, while the annual FY2021 figure was $3000.0, 72.73% down from the prior year.
  • Preferred Dividend Payments for Q3 2020 was $3000.0 at Perspective Therapeutics, roughly flat from $3000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $3000.0 in Q2 2016 and bottomed at $2000.0 in Q4 2016.
  • The 5-year median for Preferred Dividend Payments is $3000.0 (2016), against an average of $2771.5.
  • The largest annual shift saw Preferred Dividend Payments tumbled 33.33% in 2016 before it grew 12.87% in 2017.
  • A 5-year view of Preferred Dividend Payments shows it stood at $2000.0 in 2016, then changed by 0.0% to $2000.0 in 2017, then changed by 0.0% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then soared by 50.0% to $3000.0 in 2020.
  • Per Business Quant, the three most recent readings for CATX's Preferred Dividend Payments are $3000.0 (Q3 2020), $3000.0 (Q2 2020), and $3000.0 (Q1 2020).